Clinical management, expectations, and satisfaction of patients with moderate to severe allergic rhinoconjunctivitis treated with SQ-standardized grass-allergen tablet under routine clinical practice conditions in Spain

BACKGROUND: Sublingual immunotherapy has been proven as a well-tolerated and effective treatment for allergic rhinitis. Within this type of treatment, GRAZAX(®) is the most documented product in terms of safety and efficacy. The objective of this study was to identify the patients’ expectations and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chivato, Tomás, Álvarez-Calderón, Pedro, Panizo, Carmen, Abengozar, Ricardo, Alías, César, Al-Baech, Ali, Arias-Irigoyen, José, Caballero, M. José, Conill, Lluis, de Miguel, Silvia, Laguna, Rafael, Martínez-Benazet, Joan, Matoses, Francisco, Martínez-Alonso, Jose Camilo, Mendizábal, Lourdes, Pérez-Carral, Celsa, Puerto, Carlos, Serra-Batllés, Joan, Vélez, Adolfo, Vicente, Jonathan, de la Torre, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234098/
https://www.ncbi.nlm.nih.gov/pubmed/28096738
http://dx.doi.org/10.1186/s12948-016-0057-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234098/
https://www.ncbi.nlm.nih.gov/pubmed/28096738
http://dx.doi.org/10.1186/s12948-016-0057-9

Ejemplares similares